Philip Morris International Inc. (PM)
Philip Morris Rally Is Well Deserved - Upgrade To Buy At Dips
Philip Morris' premium valuations are justified by the recent US FDA approval for ZYN, attributed to the Nicotine Pouches segment's undeniable growth driver prospects. This is on top of the robust smoke-free growth across IQOS's growing users/ market share, richer overall operating margins, and a healthier balance sheet. These reasons are likely why the PM stock continues to outperform the wider market and its tobacco peers, as it emerges as the undisputed king in the tobacco market.
Philip Morris mulling $1bn sale of cigar business - report
Philip Morris International Inc is reportedly mulling the sale of its cigar business in the US under a wider shift to smoke-free products. According to Bloomberg, advisers had been brought in to gauge buyer interest over a potential sale.
Philip Morris International Inc. (PM) Consumer Analyst Group of New York Conference (CAGNY) 2025 (Transcript)
Philip Morris International Inc. (NYSE:PM ) Consumer Analyst Group of New York Conference (CAGNY) 2025 February 19, 2025 1:00 PM ET Company Participants Jacek Olczak - Chief Executive Officer Emmanuel Babeau - Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Bonnie Herzog Hi everyone, thanks so much for joining us today. It's a pleasure to welcome Philip Morris International back to CAGNY this year, including Jacek Olczak, Chief Executive Officer; and Emmanuel Babeau, Chief Financial Officer.
Philip Morris International Shares Surge as Transformation Continues. Is It Too Late to Buy the Stock?
While investors in the tobacco space have tended to be more focused on dividends over the years, Philip Morris International (PM 1.29%) has quietly turned itself into a strong growth company as its smoke-free business continues to drive strong results. The company's shares were once again climbing following its fourth-quarter earnings results.
2 Stocks to Shield Your Portfolio from AI and Tech Froth
In the current state of the stock market, investors argue over whether valuations are too high. Some see historical indicators as signs of doom, while others feel that future earnings will justify prices.
Philip Morris: No Margin Of Safety
Philip Morris delivered strong Q4 results, surpassing EPS and revenue estimates, driven by surging demand for non-traditional products like IQOS and ZYN. Non-traditional products now represent 40% of total revenue, significantly boosting gross profits. Despite strong performance and profitability, I maintain a hold rating due to Philip Morris' high valuation with a forward P/E ratio of 18.7X.
Philip Morris CEO on the growing demand for Zyn
Jacek Olczak, Philip Morris International CEO, joined CNBC's "Money Movers" on Thursday and discussed the growing demand for Zyn.
Philip Morris Q4 Earnings & Sales Beat Estimates, Stock Rallies
PM's fourth-quarter 2024 results reflect increased earnings and sales on robust momentum across all regions.
Philip Morris International Inc. (PM) Q4 2024 Earnings Call Transcript
Philip Morris International Inc. (NYSE:PM ) Q4 2024 Earnings Conference Call February 6, 2024 9:00 AM ET Corporate Participants James Bushnell - Vice President, Investor Relations and Financial Communications Jacek Olczak - Chief Executive Officer Emmanuel Babeau - Chief Financial Officer Conference Call Participants Matt Smith - Stifel Bonnie Herzog - Goldman Sachs Gaurav Jain - Barclays Eric Serotta - Morgan Stanley Faham Baig - UBS Philip Spain - JPMorgan Operator Good day and thank you for standing by. Welcome to the Philip Morris International Fourth Quarter 2024 and Full Year Results Conference Call.
Philip Morris CEO: We're pleased with FDA approval of Zyn
Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent earnings.
Philip Morris Tops Q4 Revenue Forecast
Global tobacco company Philip Morris International (PM 9.44%) reported fourth-quarter and full-year 2024 earnings on Thursday, Feb. 6, that exceeded analysts' consensus expectations. Adjusted EPS of $1.55 came in just ahead of the estimated $1.50 and revenue of $9.71 billion surpassed the forecasted $9.44 billion.
Philip Morris (PM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Philip Morris (PM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
